| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8219992 | International Journal of Radiation Oncology*Biology*Physics | 2014 | 6 Pages |
Abstract
LEM IV predicts a clinically significant increase of the RBE-weighted tolerance doses for the temporal lobe as compared to the currently applied LEM I. The limited available photon data do not allow a final conclusion as to whether RBE predictions of LEM I or LEM IV better fit better clinical experience in photon therapy. The decision about a future clinical application of LEM IV therefore requires additional analysis of temporal lobe reactions in a comparable photon-treated collective using the same dosimetric variable as in the present study.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Clarissa Gillmann, Oliver PhD, Ingmar MD, Christian P. PhD,